CAJ | 학술논문

目的：探讨癌痛患者药学监护的模式与效果。方法采用WHO合理用药调研方法，通过了解和分析癌痛患者药物治疗的情况及其中存在的问题，提出药物治疗建议，制订个体化药学监护计划，实施全程药学监护。结果50例癌痛患者的疼痛评分(NRS)由(4.9依1.6)分降低为(1.7依0.7)，较干预前降低，差异有高度统计学意义(P<0.01)；50例患者用药依从性与药学监护前相比有显著提高，差异有高度统计学意义(P<0.01)；药物不良反应改善。结论临床药师参与癌痛控制，可减轻患者癌痛，提高用药依从性，改善药物不良反应。
목적：탐토암통환자약학감호적모식여효과。방법채용WHO합리용약조연방법，통과료해화분석암통환자약물치료적정황급기중존재적문제，제출약물치료건의，제정개체화약학감호계화，실시전정약학감호。결과50례암통환자적동통평분(NRS)유(4.9의1.6)분강저위(1.7의0.7)，교간예전강저，차이유고도통계학의의(P<0.01)；50례환자용약의종성여약학감호전상비유현저제고，차이유고도통계학의의(P<0.01)；약물불량반응개선。결론림상약사삼여암통공제，가감경환자암통，제고용약의종성，개선약물불량반응。
Objective To investigate the pattern and effect of pharmaceutical care for cancer pain patients. Methods The investigation was carried out by using the researching methods of WHO rational drug use. Through understanding and analyzing the situation and problem in drug therapy for cancer pain patients, forward suggestion was putted by clinical pharmacists, individualized pharmaceutical care plan was developed and total pharmaceutical care was actual-ized. Results The NRS scores of 50 cases of patients with cancer pain was decreased from (4.9±1.6) scores to (1.7±0.7) scores, which was significantly lower than that before intervention (P < 0.01). The compliance with medication of 50 cases of patients was greatly improved comparing with that before pharmaceutical care (P<0.01). The adverse drug re-actions was improved. Conclusion Clinical pharmacists participating in the control of cancer pain can reduce the can-cer pain of patients, improve compliance with medication and adverse drug reactions.